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Abstract
Purpose: To validate a machine learning approach to Virtual intensity-modulated
radiation therapy (IMRT) quality assurance (QA) for accurately predicting gamma
passing rates using different measurement approaches at different institutions.
Methods: A Virtual IMRT QA framework was previously developed using a machine
learning algorithm based on 498 IMRT plans, in which QA measurements were per-
formed using diode-array detectors and a 3%local/3 mm with 10% threshold at Insti-
tution 1. An independent set of 139 IMRT measurements from a different institution,
Institution 2, with QA data based on portal dosimetry using the same gamma index,
was used to test the mathematical framework. Only pixels with ≥10% of the maximum
calibrated units (CU) or dose were included in the comparison. Plans were character-
ized by 90 different complexity metrics. A weighted poison regression with Lasso reg-
ularization was trained to predict passing rates using the complexity metrics as input.
Results: The methodology predicted passing rates within 3% accuracy for all com-
posite plans measured using diode-array detectors at Institution 1, and within 3.5%
for 120 of 139 plans using portal dosimetry measurements performed on a per-
beam basis at Institution 2. The remaining measurements (19) had large areas of
low CU, where portal dosimetry has a larger disagreement with the calculated dose
and as such, the failure was expected. These beams need further modeling in the
treatment planning system to correct the under-response in low-dose regions.
Important features selected by Lasso to predict gamma passing rates were as fol-
lows: complete irradiated area outline (CIAO), jaw position, fraction of MLC leafs
with gaps smaller than 20 or 5 mm, fraction of area receiving less than 50% of the
total CU, fraction of the area receiving dose from penumbra, weighted average
irregularity factor, and duty cycle.
Conclusions: We have demonstrated that Virtual IMRT QA can predict passing rates
using different measurement techniques and across multiple institutions. Prediction of
QA passing rates can have profound implications on the current IMRT process.
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1 | INTRODUCTION
Over 50% of cancer patients receive radiotherapy as partial or full cancer
treatment, and radiotherapy is an increasingly complex process. Machine
learning is a subfield of data science that focuses on designing algo-
rithms that can learn from and make predictions on data. Machine learn-
ing applications in radiotherapy have emerged increasingly in recent
years, with applications including predictive modeling of treatment out-
come in radiation oncology,1–7 treatment optimization,8–11 error detec-
tion and prevention,12–15 and treatment machine quality assurance
(QA).16–19 These machine learning techniques have provided physicians
and physicists information for more effective and accurate treatment
delivery as well as the ability to achieve personalized treatment.
To the best of our knowledge, however, little work with machine
learning has been explored in the field of dosimetry and QA in clinical
radiotherapy. It is common to perform patient-specific pretreatment
verification prior to intensity-modulated radiation therapy (IMRT)
delivery. This process is time consuming and not altogether instructive
due to the myriad of sources that affect a passing result. In an earlier
work, a machine learning algorithm, Virtual IMRT QA, was developed
that can predict IMRT QA passing rates and identify underlying
sources of errors not otherwise apparent.20 The algorithm identified
the correlation between the IMRT plan complexity metrics and gamma
passing rates and was validated on a single planning/delivery platform.
The objective of this study is to further validate the approach using a
large, heterogeneous dataset using different QA measurement devices
(diode-array detectors and portal dosimetry) on different models of
treatment machines and at different institutions.
Identifying plans prone to QA failure allows physicists to concen-
trate resources in developing proactive approaches to QA and pro-
vides information on sources of errors needed to strategically
improve the workflow of patient care as described in AAPM TG-
100.21 Goals of this study are to provide a framework to establish
universal standards and thresholds, intercompare results, safely and
efficiently implement adaptive radiotherapy, and in the long term,
eliminate failing QA altogether. This represents a fundamental para-
digm change in the way in which QA is performed.
2 | MATERIALS AND METHODS
2.A | Methodologies and data collection
The Virtual IMRT QA framework was previously developed based on
498 IMRT plans, 416 and 82 using 6 and 15 MV, respectively, on
TrueBeam and Clinac IX treatment units (Varian Medical Systems,
Palo Alto, CA, USA), measured using a diode-array detector
(MapCHECK2, Sun Nuclear Corp) with a gamma criteria of 3%lo-
cal/3 mm and 10% threshold. For each plan, parameters were
extracted from the Eclipse treatment planning system (AAA, v11.0
– Varian Medical Systems, Palo Alto, CA, USA) using SQL queries.
In order to further validate the framework, over 200 additional
IMRT measurements (139 and 64 using 6 and 15 MV, respec-
tively) based on Varian portal dosimetry (PD) on a Trilogy Linac at
the Memorial Sloan Kettering Cancer Center (MSKCC) were tested
using the same gamma criteria. The electronic portal imaging
device (EPID) used in this study is a Varian aS1000 model with a
pixel resolution of 0.392 mm and maximum image acquisition rate
of 30 frames per second. The dark and flood field calibration
along with a 10 9 10 cm, 100 MU at the source-to-detector dis-
tance of 105 cm were performed every day before QA to guaran-
tee consistency of the measurements. Automatic registration was
used to align the absolute dose distributions and analysis was per-
formed using a gamma criteria 3%local/3 mm. For each IMRT
beam, control point information was extracted from Eclipse v11.0
and different features that characterize the plans, Table 1, were
TAB L E 1 Sample variables in Virtual IMRT QA modeling
(continuous variables >90).
Number Variable Possible value
1 QA device MapCHECK2, Portal dosimetry
2 Energy 6 MV, 15 MV
3 Machine type TrueBeam, Trilogy, 21IX, 21EX,
6EX
4 Collimator angle Mean value averaged over all
control points
5 CIAO area
(i.e., 5–>5 9 5)
<5, 5–10, 10–15, 15–20, 20–25,
25–30, >30
6 Jaw position <5, 5–10, 10–15, 15–20,
20–25, >25
7 Small aperture score Fraction of MLC gaps <2, 5, 10,
20 mm
8 Fraction of area
receiving at least
x% of CU
10, 20, 30, 40, 50
9 Irregularity factor Fraction of area outside
Radius = 5, 10, 20 cm
10 MLC leaf transmission HD, M120-pre-2007,
M120-post-2007
11 Perimeter <10, 10–30, 30–50, 50–70, 70–90,
90–110, >110
12 Duty cycle (Total
MU/Dose)
<2, 3–3, 3–4, 4–5, 5–6, >6
13 Modulation factor Overall complexity (1, 2, 3)
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calculated using Matlab Scripts, Matlab Inc, MA. Using all features
and the corresponding passing rate, multivariate analysis was per-
formed to identify the most important features that govern the
passing rate. Poisson regression with Lasso regularization was
trained using the new dataset acquired at MSKCC to learn the
relation between the plan characteristics and each passing rate.
Other details can be found in the original publication on the
development of the Virtual IMRT QA method.20 Figure 1 summa-
rizes the entire workflow of the construction and validation of the
predictive IMRT QA model.
For the portal dosimetry, only pixels with ≥10% of the maximum
calibrated units (CU) or dose were included in the comparison. Plans
were characterized by 90 different complexity metrics. A weighted
poison regression with Lasso regularization was trained to predict
passing rates using the complexity metrics as an input.
2.B | Weighted Poisson regression with Lasso
regularization
Let S = [(x1,y1), . . . (xn,yn)] be a set of paired data, where yi is the
number of detectors (pixels) that fail IMRT QA and xi is a vector
of complexity metrics of length 90 + 1 (as x1 is set to 1). Now
let us assume that the number of measurement points that fail
follows a Poisson distribution, as it is customary when counts are
modeled:
p y ¼ yijDi; fr xið Þð Þ ¼ Di  fr xið Þð Þ
yi eDifr xið Þ
yi!
: (1)
where Di is the total number of detectors in the analysis and fr xið Þ is
the mean value of the failing rate of the plan i that depends on its
complexity vector xi.
We can model fr according to a Poisson regression as:
fr xið Þ ¼ eb
Txi (2)
where b is a constant vector the same size as xi
Now, given the realization of the data S, let us find the most
likely vector b. In order to obtain b, we use Bayes theorem:
p bjSð Þ ¼ p Sjbð Þ  p bð Þ
p Sð Þ (3)
where p bjSð Þ is the posterior probability of b given S, p Sjbð Þ is the
probability of obtaining S given b, p bð Þ is the prior probability of b,
and p Sð Þ is the probability of obtaining S regardless of b. We are
interested in finding the b that maximizes the function p bjSð Þ, which
is the same as:
argmaxbp bjSð Þ ¼ argmaxb p Sjbð Þ  p bð Þp Sð Þ ¼ argmaxb p Sjbð Þ  p bð Þ (4)
In eq. 4 we have taken into account that p Sð Þ does not depend
on b and as such, it can be dropped from the optimization problem.
Assuming all measurements xi; yið Þ are conditionally independent
given the model, the probability p Sjbð Þ can be written as:
p Sjbð Þ ¼
Yn
i¼1
Di  ebTxi
 yi
eDie
bT xi
yi!
(5)
And assuming a Laplace distribution with a mean of 0 and vari-
ance equal to 2k2 for p bð Þ, as customary in Lasso regularization, we
have
p bð Þ ¼ 1
2k
e bj j=k (6)
which results in:
argmaxb p bjSð Þ ¼ argmaxb
Yn
i¼1
Di  ebTxi
 yi
eDie
bT xi
yi!
 1
2k
e bj j=k
2
64
3
75 (7)
As maximizing p bjDð Þ is equivalent to maximizing log(p bjDð ÞÞ,
eq. 7 can be rewritten as:
argmaxb log p bjSð Þð Þ ¼
argmaxblog
Yn
i¼1
Di  ebTxi
 yi
eDie
bT xi
yi!
 1
2k
e bj j=k
0
B@
1
CA
Applying the rules of logarithms and dropping the terms that do
not depend on b results in:
F I G . 1 . The workflow of the validation
of Virtual IMRT QA model.
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argminb log p bjSð Þð Þ ¼ argminb 
Xn
i¼1
wi frib
Txi  eb
Txi
 
þ k bj j
" #
(8)
where fri is the observed failing rate for plan i, wi = Di./Dmax is a
weight factor for each observation proportional to the number of
detectors in the measurement and Dmax is a normalization constant.
Equation 8 is a weighted Poisson regression problem with Lasso reg-
ularization where bT can be obtained using the software package
available at https://web.stanford.edu/~hastie/glmnet/glmnet_alpha.
html.
Once bT is obtained, this constant vector is used together with
eq. 2 and the complexity metrics of each plan xi to predict a specific
plan’s passing rates as:
fri ¼ eb
Txi (9)
3 | RESULTS
Equation 9 was used to construct histograms of measured versus
predicted passing rates using a 3%/3 mm local gamma threshold
(Figs. 2 and 3). This magnitude commonly called residual is the stan-
dard metric to evaluate the performance of regression algorithm in a
similar way that Area Under the Curve is used to evaluate perfor-
mance in classification algorithms.22 All composite plans measured
using diode-array detectors were predicted within 3% accuracy2,
while passing rates for portal dosimetry on per-beam basis were pre-
dicted within <3.5% for 120 IMRT measurements delivered with
6 MV. The remaining measurements that used 6 MV (19) had large
areas of low CU, where portal dosimetry exhibits poorer agreement
with the calculated dose. This is due to the difference in response of
an a-Si electronic portal imaging device to open and MLC transmit-
ted radiation, and further modeling using an algorithm such as that
presented by Vial et al. can improve the under-response in low-dose
regions.23,24 These 19 IMRT beams with mean CU value of
0.127  0.071 (range 0.022–0.254) have been excluded from the
study pool. From the machine learning analysis, the important fea-
tures selected by Lasso to predict gamma passing rates when the
model was trained with MSKCC data were as follows: complete irra-
diated area outline (CIAO) area, jaw position, fraction of MLC leafs
with gaps smaller than 20 or 5 mm, fraction of area receiving less
than 50% of the total CU, fraction of the area receiving dose from
penumbra, weighted average irregularity factor, and duty cycle
among others. These features are the most likely feature to result in
plans failing QA at different institutions that also use EPID dosime-
try. Their specific quantitative contribution to the failing rate, how-
ever, will depend on the underlying model at each individual clinic.
In addition, please note that all predictions are out of sample predic-
tion, that is, the passing rates being predicted are not part of the
data used to train the model.
Finally, a learning curve experiment was performed to estimate
the number of plans needed in order for the model to converge to a
solution. To evaluate confident intervals for the model, we
constructed models by varying the number of training samples and
calculating the training and testing error. The process was repeated
10 times and confident intervals calculated. Figure 4 shows that
after approximately 80 data patients, no further improvement is
obtained on average in the testing error. This number is roughly half
the number obtained by Valdes et al.20 confirming that if the data
are more homogeneous, that is, for Institution 2, only data from one
Linac were analyzed, a smaller number of data points are needed to
obtain a stable model.
4 | DISCUSSION
An algorithm using machine learning, Virtual IMRT QA, has been
developed to correlate the characteristics of IMRT plan and delivery
characteristics and the corresponding gamma passing rate. With
some adjustments on the features in the original model, Poisson
regression with Lasso regularization was trained to learn the relation
between the plan characteristics and each passing rate for different
measurement devices. The predictive model was validated for differ-
ent QA devices and methodologies on seven Linacs across two insti-
tutions. With our validation results, Virtual IMRT QA can predict
gamma passing rates accurately within 3.5% as maximum empirical
error observed. In addition, our previous work showed that 200
patient-specific QA plans and results are required to train the virtual
QA model to achieve an accurate prediction.20 The required training
QA data should be readily available assuming a measurement-based
clinical patient-specific QA program is in place, and should not
impose additional measurement burden on the practicing physicist.
The potential benefit of this approach can be quite significant. For
instance, Virtual IMRT QA could be run by the dosimetrist while
planning. If an arbitrary threshold of 93.5% for Virtual IMRT QA is
set, all plans that satisfy this threshold should pass IMRT QA with a
passing rate higher than 90%. These plans could be further mea-
sured. However, those that have predicted passing rate smaller than
93.5% could be modified without the need to perform the QA
-4 -3 -2 -1 0 1 2 3 4
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F I G . 2 . Residual error for Clinac and TrueBeam Linacs measured
using MapCHECK2 at Institution 1.
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potentially saving valuable time. In addition to single gamma results,
this model provides insight into factors contributing to the resulting
failure points by identifying relevant features. This allows physicists
to quantitatively assess different risk factors-associated treatment
plans. As TG-100 calls for a new risk-based QA program, this virtual
QA model can be an invaluable tool to assist clinical physicists in
their implementation. The virtual QA approach is not intended to
replace measurement-based QA, but rather to complement the mea-
surement-based program to provide a more comprehensive view.
Through workflow improvement and risk analysis, the tool should
enhance the overall QA and improve the safety of treatment
delivery.
At present, the model is only capable of assessing fixed-beam
IMRT planning/delivery; features critical to volumetric-modulated
radiotherapy (VMAT) will be incorporated into future machine
learning models. This should be acknowledged as a limitation of the
current method. Analysis of 3D detectors will require the collection
of some of the key delivery information, such as gantry speed, MLC
speed, and aperture size, and obtaining these parameters posts
potential challenges. With the popularity of this treatment modality,
further study in this direction will be a great asset to the community.
In addition, the predictive model was trained to correlate the auto-
matic registration of calculated and measured QA doses which has
its pros (uncertainty due to phantom misalignment is removed) and
cons (some mechanical errors producing a shift of dose are not
detected in QA).
In this study, we have used the formalism as described by Valdes
et al.20 From eq. 9, however, it is clear that contributions from the
different metrics were assumed to be linear (multiplication of a con-
stant vector by the vector describing the plan characteristics), that is,
no interaction terms between the different characteristics were con-
sidered. In addition, at the current stage, different models are
needed for different combinations of delivery systems and energies.
Ideally, one would like to incorporate all the data from an institution
(delivery device, energy, QA devices, etc.) and input this data into a
single mathematical formulation that will predict the gamma passing
rate without the need for independent models which increases the
data requirement. Even though beam data models for different
Linacs/energies are different, they do share important characteristics
and from an analytics point of view, it is inefficient to segregate the
data by imposing practical constraints. We are currently developing
a formulation that will take into account these limitations in order to
obtain errors of local gamma passing rates within 2%. This number
should be the ultimate goal of any quantitative analysis predicting
gamma passing rate because as it has been reported by Nelms et al.,
some clinical relevant errors could create changes in gamma passing
rate in the order of 2%.25 One possible way to improve accuracy
within the current framework would be to separate data by treat-
ment site and build a model for each treatment site. As in the case
of different models for different energies, this approach will increase
-4 -3 -2 -1 0 1 2 3
Predicted - Measured
0
5
10
15
20
25
30
35
40
N
um
be
r o
f p
la
ns
Out of Sample
F I G . 3 . Residual error for a Trilogy (6 MV) at using portal
dosimetry at Institution 2. Note that the inherent Varian’s Portal
Dose Image Prediction algorithm assumes a radially symmetric
response which is certainly different than the reality in 2D profiles
of portal dosimetry.23 This may add the additional uncertainty of this
measurement.
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the need for more data. Finally, although we have decided to model
here gamma passing rate with 3%/3 mm local analysis (for small tar-
gets 3%/2 mm might be more appropriate in the conventional QA),
our methodology should not depend on the % dose or distance to
agreement selected. That being said, at least in our dataset, stricter
metric than 3%/3 mm results in having too much inherent noise for
proper modeling.
5 | CONCLUSIONS
In this work with more extensive QA data, the validity of Virtual
IMRT QA to accurately predict gamma passing rates, within 3.5%
error, has been shown for different models of Linacs in different
institutions, providing a strong validation of our IMRT QA predictive
model. Compared to conventional measurement-based QA, the
framework also provides significant insight into both machine and
plan characteristics. Software-based, Virtual IMRT QA using machine
learning has a unique position in the radiotherapy QA program and
further provides a framework for a future integrated risk-based QA
program such as that envisioned in AAPM TG-100.
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